Page last updated: 2024-11-06

floxuridine and Dyspepsia

floxuridine has been researched along with Dyspepsia in 1 studies

Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.

Dyspepsia: Impaired digestion, especially after eating.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chuang, VP1
Wallace, S1
Stroehlein, J1
Yap, HY1
Patt, YZ1

Other Studies

1 other study available for floxuridine and Dyspepsia

ArticleYear
Hepatic artery infusion chemotherapy: gastroduodenal complications.
    AJR. American journal of roentgenology, 1981, Volume: 137, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Blood Vessels; Cisplatin; Duodenum; Dyspepsia; Female; Floxuridi

1981